Case Study - Pipeline Assessment Consulting Services

Objective :

Assessment of pipeline activities around client’s area of interest to support strategic decisions

Problem Statement:

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.

Our Methodology:

Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
Company Assessment via Funding/Collaboration/Partnership Analysis
Analyst Comments on R&D developments

Results:

Detailed pipeline profiles of T-Cell Receptor (TCR) products
Additional comments on Inactive (Discontinued and Dormant) products.
Therapeutic assessment of active pipeline products
Detailed profiles of Companies with key coverage of collaboration/partnering activities

Related case Studies

Due Diligence R&D Analysis Out-Licensing Opportunity Portfolio Management Go-To-Market Strategy Asset Prioritization Mergers and Acquisitions

Sample Visuals

Get Visuals

Related Insights

Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

View Case

R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

View Case